Approvals/TGA/NANOPACLICIP Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial

Approved

STANDARD

NANOPACLICIP Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: af3324a2cb0e02e8
Product Name: NANOPACLICIP Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial
Artg Id: 328528
Artg Name: NANOPACLICIP Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2020-10-29
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

af3324a2cb0e02e8

Type

Standard